Related references
Note: Only part of the references are listed.DNA Prime/Adenovirus Boost Malaria Vaccine Encoding P-falciparum CSP and AMA1 Induces Sterile Protection Associated with Cell-Mediated Immunity
Ilin Chuang et al.
PLOS ONE (2013)
Next Generation Sequencing to Detect Variation in the Plasmodium falciparum Circumsporozoite Protein
Kavita Gandhi et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2012)
Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine
Nicole Frahm et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Use of Massively Parallel Pyrosequencing to Evaluate the Diversity of and Selection on Plasmodium falciparum csp T-Cell Epitopes in Lilongwe, Malawi
Jeffrey A. Bailey et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
CD8 T Cell Epitope Distribution in Viruses Reveals Patterns of Protein Biosynthesis
Carmen M. Diez-Rivero et al.
PLOS ONE (2012)
Genetic Variation in the Plasmodium falciparum Circumsporozoite Protein in India and Its Relevance to RTS,S Malaria Vaccine
Mohammad Zeeshan et al.
PLOS ONE (2012)
Unexpected fold in the circumsporozoite protein target of malaria vaccines
Michael B. Doud et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
HLA class I allele promiscuity revisited
Xiangyu Rao et al.
IMMUNOGENETICS (2011)
The malaria circumsporozoite protein has two functional domains, each with distinct roles as sporozoites journey from mosquito to mammalian host
Alida Coppi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
CD8+ T Effector Memory Cells Protect against Liver-Stage Malaria
Arturo Reyes-Sandoval et al.
JOURNAL OF IMMUNOLOGY (2011)
Measuring naturally acquired immune responses to candidate malaria vaccine antigens in Ghanaian adults
Daniel Dodoo et al.
MALARIA JOURNAL (2011)
Adenovirus 5-Vectored P. falciparum Vaccine Expressing CSP and AMA1. Part A: Safety and Immunogenicity in Seronegative Adults
Martha Sedegah et al.
PLOS ONE (2011)
Adenovirus-5-Vectored P. falciparum Vaccine Expressing CSP and AMA1. Part B: Safety, Immunogenicity and Protective Efficacy of the CSP Component
Cindy Tamminga et al.
PLOS ONE (2011)
Structure of the Plasmodium falciparum Circumsporozoite Protein, a Leading Malaria Vaccine Candidate
Matthew L. Plassmeyer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Immunological mechanisms underlying protection mediated by RTS,S: a review of the available data
Vasee S. Moorthy et al.
MALARIA JOURNAL (2009)
Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance
Stefan Tenzer et al.
NATURE IMMUNOLOGY (2009)
Meta-analysis of immune epitope data for all Plasmodia: overview and applications for malarial immunobiology and vaccine-related issues
K. Vaughan et al.
PARASITE IMMUNOLOGY (2009)
Viral vectors in malaria vaccine development
K. J. Limbach et al.
PARASITE IMMUNOLOGY (2009)
HLA class I supertypes: a revised and updated classification
John Sidney et al.
BMC IMMUNOLOGY (2008)
Evaluation of MHC class I peptide binding prediction servers: Applications for vaccine research
Hong Huang Lin et al.
BMC IMMUNOLOGY (2008)
Safety and Immunogenicity of an AMA-1 Malaria Vaccine in Malian Adults: Results of a Phase 1 Randomized Controlled Trial
Mahamadou A. Thera et al.
PLOS ONE (2008)
Extensive HLA class I allele promiscuity among viral CTL epitopes
Nicole Frahm et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
A role for apical membrane antigen 1 during invasion of hepatocytes by Plasmodium falciparum sporozoites
O Silvie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Definition of supertypes for HLA molecules using clustering of specificity matrices
O Lund et al.
IMMUNOGENETICS (2004)
Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities
N Frahm et al.
JOURNAL OF VIROLOGY (2004)
Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data
DL Doolan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Reliable prediction of T-cell epitopes using neural networks with novel sequence representations
M Nielsen et al.
PROTEIN SCIENCE (2003)
A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays
JR Currier et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2002)
Induction of CD4+ T cell-dependent CD8+ type 1 responses in humans by a malaria DNA vaccine
RB Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)